TANANARIEVE BROWN: Open Payments
NPI 1306175203 · DAYTONA BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$918 in 41 payments from 8 companies in 2025. Trend: 2023 $1,151 · 2024 $1,203 · 2025 $918
Food & beverage: $818Education: $100
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 18 | $371 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $196 |
| Teva Pharmaceuticals USA, Inc. | 4 | $137 |
| Neurocrine BioSciences, Inc. | 4 | $91 |
| Otsuka America Pharmaceutical, Inc. | 3 | $59 |
| Alkermes, Inc. | 1 | $25 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
| ABBVIE INC. | 1 | $19 |
Products named: COBENFY, CAPLYTA, INGREZZA, ABILIFY ASIMTUFII, UZEDY, LYBALVI, REXULTI, INVEGA SUSTENNA.
Industry payments across FL — which companies pay providers there.
